ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    The Impact of Frailty Syndrome on Humoral Response to SARS-CoV-2 mRNA Vaccines in Older Kidney Transplant Recipients

    M. Schmalz1, H. Vankova2, S. Rajnochova-Bloudickova1, P. Hruba3, M. Fialova4, J. Gurka5, M. Magicova1, I. Striz4, I. Zahradka1, O. Viklicky1

    1Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 2The Third Faculty of Medicine, Charles University, Prague, Czech Republic, 3Transplantation Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 4Department of Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 5Department of Information Technology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

    *Purpose: Advanced age is associated with impaired humoral immune response to SARS-CoV-2 mRNA vaccines in kidney transplant recipients (KTR), however mechanisms are poorly understood. Frailty…
  • 2022 American Transplant Congress

    A Successful Expansion of Donor Liver Supply is Feasible with the Selective Use of Older DCD Livers

    M. Finotti, M. Rosenzweig, A. Wall, S. H. Lee, A. Gupta, J. Bayer, H. Fernandez, N. Onaca, R. Ruiz, G. Testa, G. J. McKenna

    Baylor Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX

    *Purpose: DCD are a key way to expand the donor pool, yet many centers are hesitant about using anything but the most favorable DCD allografts,…
  • 2022 American Transplant Congress

    Evolution of Donation After Circulatory Death Liver Transplantation in the United States

    M. Finotti, G. McKenna, J. Bayer, H. Fernandez, S. Lee, E. Martinez, N. Onaca, G. Saracino, R. Ruiz, G. Testa, A. Gupta, A. Wall

    Baylor University Medical Center/Baylor Simmons Transplant Institute, Dallas, TX

    *Purpose: With the shortage of organs for liver transplantation (LT), different solutions have been proposed to expand the donor pool: utilization of extended criteria organs,…
  • 2022 American Transplant Congress

    Use of Belatacept in Non-Compliant Adolescent Patients

    C. McAdams1, C. Gluck1, E. Hilmas2

    1Nemours Children's Health, Wilmington, DE, 2Nationwide Children's Hospital, Columbus, OH

    *Purpose: Adolescents are at high risk for kidney transplant rejection due to non-compliance. While intravenous (IV) maintenance medications are FDA approved for adults, there is…
  • 2022 American Transplant Congress

    Infections Following Rejection Therapies in Solid Organ Transplant Recipients

    S. Gupta1, J. Gea-Banacloche2, H. Me3, D. M. Chascsa4, H. R. Vikram2, R. Yaman1, L. Kodali3

    1Internal Medicine, Mayo Clinic, Scottsdale, AZ, 2Infectious Diseases, Mayo Clinic, Phoenix, AZ, 3Transplant Nephrology, Mayo Clinic, Phoenix, AZ, 4Hepatology, Mayo Clinic, Phoenix, AZ

    *Purpose: Infections are known complications of solid-organ transplant. They are most prevalent in the first 12 months after transplant when immunosuppression is at its peak.…
  • 2022 American Transplant Congress

    Efficacy and Safety of PCSK-9 Inhibitor, Evolocumab for Lipid Management in Kidney Transplant Recipients

    J. Pandav1, R. Saranu1, S. Muhsin1, N. Murakami1, S. Gabardi1, K. Safa2, A. Chandraker1

    1Renal division, Brigham and Women's Hospital, Boston, MA, 2Renal division, Massachusetts General Hospital, Boston, MA

    *Purpose: Dyslipidemia is common in kidney transplant recipients (KTRs). KDIGO guidelines suggest all KTRs should be treated with statins due to the high risk of…
  • 2022 American Transplant Congress

    Early Outcomes Since Implementation of New Kidney Allocation System

    K. Shah, F. Siddiqui, P. N. Chotai, A. Logan, A. Schenk, K. Washburn, A. Limkemann

    Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH

    *Purpose: The new Kidney allocation system (nKAS) implemented for optimization of organ placement. Like other organ allocation systems, kidney has been redefined from donation service…
  • 2022 American Transplant Congress

    The Impact of the New Allocation System of Kidney Transplantation on a Single Institution

    M. Eltemamy, Y. Lin, M. Khalil, S. Agrawal, V. Krishnamurthi, A. Wee

    The Cleveland Clinic, Cleveland, OH

    *Purpose: The new kidney allocation system went into effect in the middle of March 2021. The consequences of this new system affected transplant centers differently,…
  • 2022 American Transplant Congress

    Concordance of Kidney and Pancreas Rejection on Protocol and for Cause Biopsy in Simultaneous Kidney Pancreas Transplantation

    P. Budhiraja, R. Heilman, H. Khamash, A. Jaramillo, D. Ramon, H. Me, J. Ninan, S. Reddy, s. S. Misra, H. Chakkera

    Mayo Clinic, Phoenix, AZ

    *Purpose: Our aim was to study the concordance rate of kidney and pancreas rejection in patients who received simultaneous kidney-pancreas transplantation (SKP) and its effects…
  • 2022 American Transplant Congress

    Gene Expression Changes Including Long Non-Coding RNAs in Human Hepatic Ischemia Reperfusion Injury

    C. Kuscu1, S. Naik1, C. Eymard2, H. Ingram1, A. Bajwa1, D. Maluf3, V. Mas4, J. Eason5, C. Kuscu1

    1Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, 2James D. Eason Transplant Institute, Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, 3Surgery, University of Maryland, Baltimore, MD, 4University of Maryland, Baltimore, MD, 5University of Tennessee/Methodist Transplant Institute, Memphis, TN

    *Purpose: Ischemia reperfusion injury (IRI) is still one of the major problems in liver transplantation affecting long term outcomes. This study is sought out to…
  • « Previous Page
  • 1
  • …
  • 87
  • 88
  • 89
  • 90
  • 91
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences